What doctors measured in patients
Thymosin Alpha-1 helps guide the body's white blood cells.
See where patients improved, where they didn't, and which findings came only from animals or a lab dish.
The trials measured liver health and survival after blood poisoning
Hospital trials first asked two plain questions. Did liver disease improve, and did more patients survive severe blood poisoning? Doctors chose those questions before testing Thymosin Alpha-1. The drug copies a small protein from the thymus, a gland set behind your breastbone.
Small studies abroad reported improved liver tests in blood from patients with long-term viral disease. That doesn't show the shot helps another health problem you may have. In 2025, over a thousand people with severe blood poisoning, called sepsis, entered the largest trial while doctors watched them closely in hospital; the drug did not help more survive [3]. The drug has no approval for sale in the United States, and the Thymosin Alpha-1 effects page lets you keep personal stories apart from trial results before your next doctor visit.
01 — The drug helps white blood cells fight without harming healthy tissue
Researchers found Thymosin Alpha-1, also called Tα1, in calf thymus tissue in 1977 [1]. Cell studies show the drug starting a handoff between two groups of white blood cells [5]. One group spots a germ and teaches the other group to attack. The thymosin alpha 1 mechanism of action page tells you what later lab work on Tα1 found [11].
Tα1 may also stop an immune attack before it harms too much healthy tissue. In lab work, it helped the body's defenses kill germs while holding down that harm [5]. That balance could matter if illness has weakened your defenses. The Thymosin Alpha-1 research page labels results from patients, animals, and laboratory dishes.
02 — Liver results were hopeful, but the largest sepsis trial saved no more lives
The phase 3 TESTS trial followed 1,106 adults in 22 intensive care units, and no more people survived severe blood poisoning when they received the drug [3]. Patients given Tα1 fared no better than those given a placebo, a dummy shot. The paper's 95% check asks if chance might explain a gap, but the groups had no survival gap, so the plain patient result tells you enough. An earlier trial of 361 patients had hinted that Tα1 might help, yet the larger study of more people did not bear that out [2].
The smaller liver trials gave more hopeful results. In hepatitis B, a long-term viral liver disease, patients received shots for 24 weeks. Their blood tests still showed control of the virus at 48 weeks [8]. That narrow finding doesn't mean you can expect less tiredness or help with a different illness.
03 — The immune drug and the gym drug are different
People often mix up Thymosin Alpha-1 and thymosin beta-4, sold in some gym circles as TB-500. They aren't the same substance. In tests on human cells, Tα1 made certain white blood cells more active, while thymosin beta-4 made them less active [15]. Other thymus proteins sound similar yet serve different roles.
The thymosin alpha 1 vs thymosin beta 4 page lays out the difference. The immune drug guides white-cell work, while the gym drug appears in tissue-repair claims. If you see evidence for one, don't carry it over to the other. Keeping the names straight protects you from following the wrong claim.
Results in patients matter more than promise in a lab dish
Lab work can suggest how medicine acts. A dish cannot answer the question you care about: did patients live longer? The thymosin alpha 1 mechanism of action page covers those early tests. The what is Thymosin Alpha-1 page explains the drug's origin and names.
The Thymosin Alpha-1 research page turns next to hospital patients. It gives large, careful trials more weight than small tests in which everyone knew the treatment. Personal accounts sit apart on the Thymosin Alpha-1 effects page. This order lets you gather sound questions before you meet your doctor.
Take these facts when you see your doctor
Review TA1 sums up published trials of Thymosin Alpha-1 in plain words, and each numbered mark leads to the original paper on the Thymosin Alpha-1 references page. This isn't a clinic or a pharmacy, and nothing here is sold. Trial amounts show what doctors studied, not what you ought to take. Bring the findings and your health questions to a clinician familiar with your history.